Re: Vascular Aging in Long-Term Survivors of Testicular Cancer More than 20 Years after Treatment with Cisplatin-Based Chemotherapy

被引:0
|
作者
Richie, Jerome P.
机构
来源
JOURNAL OF UROLOGY | 2022年 / 207卷 / 02期
关键词
D O I
10.1097/JU.0000000000002322
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:470 / 470
页数:1
相关论文
共 50 条
  • [41] Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
    Agrawal, Vaibhav
    Dinh, Paul C., Jr.
    Fung, Chunkit
    Monahan, Patrick O.
    Althouse, Sandra K.
    Norton, Kelli
    Cary, Clint
    Einhorn, Lawrence
    Fossa, Sophie D.
    Adra, Nabil
    Travis, Lois B.
    JNCI CANCER SPECTRUM, 2020, 4 (02)
  • [42] Re: Cumulative Burden of Morbidity among Testicular Cancer Survivors after Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 32 - 33
  • [43] Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy
    Bagrodia, Aditya
    Lotan, Yair
    EUROPEAN UROLOGY, 2017, 72 (05) : 857 - 858
  • [44] Re: Multi-Institutional Assessment of Adverse Health Outcomes among North American Testicular Cancer Survivors after Modern Cisplatin-Based Chemotherapy
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 29 - 29
  • [45] Quality of life and cognitive functioning impairment associated with cisplatin-based chemotherapy in testicular cancer survivors.
    Chovanec, Michal
    Vasilkova, Lucia
    Setteyova, Lucia
    Rejlekova, Katarina
    Obertova, Jana
    Sycova-Mila, Zuzana
    Palacka, Patrik
    Kalayska, Katarina
    Svetlovska, Daniela
    Mladosievicova, Beata
    Mardiak, Jozef
    Mego, Michal
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Re: The Cardiac Impact of Cisplatin-Based Chemotherapy in Survivors of Testicular Cancer: A 30-Year Follow-up EDITORIAL COMMENT
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2022, 208 (05): : 1162 - 1162
  • [47] Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
    Feldman, Darren R.
    Ardeshir-Rouhani-Fard, Shirin
    Monahan, Patrick
    Sesso, Howard D.
    Fung, Chunkit
    Williams, Annalynn M.
    Hamilton, Robert J.
    Vaughn, David J.
    Beard, Clair J.
    Cook, Ryan
    Abu Zaid, Mohammad
    Lipshultz, Steven E.
    Einhorn, Lawrence H.
    Oeffinger, Kevin C.
    Travis, Lois B.
    Fossa, Sophie D.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E761 - E769
  • [48] Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study
    Kerns, Sarah L.
    Fung, Chunkit
    Monahan, Patrick O.
    Ardeshir-Rouhani-Fard, Shirin
    Abu Zaid, Mohammad I.
    Williams, AnnaLynn M.
    Stump, Timothy E.
    Sesso, Howard D.
    Feldman, Darren R.
    Hamilton, Robert J.
    Vaughn, David J.
    Beard, Clair
    Huddart, Robert A.
    Kim, Jeri
    Kollmannsberger, Christian
    Sahasrabudhe, Deepak M.
    Cook, Ryan
    Fossa, Sophie D.
    Einhorn, Lawrence H.
    Travis, Lois B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15) : 1505 - +
  • [49] Building epigenetic clocks for estimating accelerating aging in patients with testicular cancer treated with cisplatin-based chemotherapy
    Wojewodzic, Marcin W.
    Sydhagen, K. Aurora
    Rounge, Trine B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Editorial Comment on: Paternity and Testicular Function Among Testicular Cancer Survivors Treated with Two to Four Cycles of Cisplatin-Based Chemotherapy
    Salonia, Andrea
    EUROPEAN UROLOGY, 2010, 58 (01) : 140 - 141